As of May 16, 2015, a cholera outbreak was confirmed in the Kigoma region, on the shores of Lake Tanganyika, along the Tanzania border with Burundi. Cholera is endemic in the region, but due to a recent influx of thousands of Burundian refugees, overcrowding and poor sanitation, the situation got worse. As of May 28, 2015, a total of 4,487 suspected cholera cases have been reported so far.
Jacob Lusekelo, a laboratory technician. Photo courtesy of WHO/Desloovere Pieter
As of May 16, 2015, a cholera outbreak was confirmed in the Kigoma region, on the shores of Lake Tanganyika, along the Tanzania border with Burundi. Cholera is endemic in the region, but due to a recent influx of thousands of Burundian refugees, overcrowding and poor sanitation, the situation got worse. As of May 28, 2015, a total of 4,487 suspected cholera cases have been reported so far.
Since more than a week ago, laboratory scientist Jacob Lusekelo and his team have worked around the clock at Maweni Hospital in Kigoma, testing dozens of stool samples. During a cholera outbreak, 1 out of 10 stool samples need to be laboratory confirmed by identifying the bacteria Vibrio cholerae.
“The method we use to know if a stool sample tests positive for cholera or not, is called culture and sensitivity,” says Lusekel. “The lab results are known after 48 hours and it basically consists of three phases, the media or reagents preparation, the isolation to identify the organism and lastly result release and waste disposal. The media we use for doing the tests is TCBS or thiosulphate citrate bile salt sucrose. A case of cholera is confirmed when Vibrio cholerae O1 or O139 is isolated from any patient with diarrhea.”
As the laboratory team of Maweni Hospital got overwhelmed with the many stool samples to be tested, WHO facilitated additional human resource support. “Through the World Health Organization (WHO), I was able to come from Dar-es-Salaam to Maweni hospital to give the lab team a much-needed helping hand,” says Lusekelo.
In addition, medical supplies and reagents were sent to the hospital to ensure the continuation of the laboratory activities. With support of WHO, the laboratory team has been able to test so far 107 samples, including 42 samples testing positive for the virulent disease.
Source: WHO
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.